Tuberculosis associated with therapy against tumor necrosis factor α
- 30 September 2005
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (10) , 2968-2974
- https://doi.org/10.1002/art.21382
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Influence of Bacille Calmette-Guerin Vaccination on Size of Tuberculin Skin Test Reaction: To What Size?Clinical Infectious Diseases, 2005
- Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic reviewThe Lancet Infectious Diseases, 2004
- Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trialArthritis & Rheumatism, 2004
- ReplyArthritis & Rheumatism, 2004
- Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor InhibitorClinical Infectious Diseases, 2004
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance reportArthritis & Rheumatism, 2003
- Tuberculosis in the cytokine era: What rheumatologists need to knowArthritis & Rheumatism, 2003
- Infectious complications of biologic treatments of rheumatoid arthritisCurrent Opinion in Rheumatology, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001